KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Return on Assets (2016 - 2025)

Biomarin Pharmaceutical (BMRN) has disclosed Return on Assets for 16 consecutive years, with 0.09% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Return on Assets rose 5.0% year-over-year to 0.09%, compared with a TTM value of 0.09% through Jun 2025, up 5.0%, and an annual FY2025 reading of 0.05%, down 1.0% over the prior year.
  • Return on Assets was 0.09% for Q2 2025 at Biomarin Pharmaceutical, up from 0.07% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.09% in Q2 2025 and bottomed at 0.01% in Q4 2021.
  • Average Return on Assets over 5 years is 0.03%, with a median of 0.02% recorded in 2022.
  • The sharpest move saw Return on Assets dropped -15bps in 2021, then increased 5bps in 2025.
  • Year by year, Return on Assets stood at 0.01% in 2021, then surged by 309bps to 0.02% in 2022, then crashed by -50bps to 0.01% in 2023, then soared by 452bps to 0.06% in 2024, then surged by 46bps to 0.09% in 2025.
  • Business Quant data shows Return on Assets for BMRN at 0.09% in Q2 2025, 0.07% in Q1 2025, and 0.06% in Q4 2024.